Cargando…

Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies

Detalles Bibliográficos
Autores principales:	Lewis, Alexander C., Wallington-Beddoe, Craig T., Powell, Jason A., Pitson, Stuart M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257673/ https://www.ncbi.nlm.nih.gov/pubmed/34226526 http://dx.doi.org/10.1038/s41420-020-00380-1

Ejemplares similares

Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies
por: Lewis, Alexander C., et al.
Publicado: (2018)

Enhancing ER stress in myeloma
por: Wallington-Beddoe, Craig T., et al.
Publicado: (2017)

Novel therapies for multiple myeloma
por: Wallington-Beddoe, Craig T., et al.
Publicado: (2017)

Ferroptosis in Haematological Malignancies and Associated Therapeutic Nanotechnologies
por: Mynott, Rachel L., et al.
Publicado: (2023)

The sphingosine 1-phosphate receptor 2/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism
por: Pitman, Melissa R., et al.
Publicado: (2022)

Author Correction: Candida albicans gains azole resistance by altering sphingolipid composition
por: Gao, Jiaxin, et al.
Publicado: (2019)

Author Correction: Particular CSF sphingolipid patterns identify iNPH and AD patients
por: Torretta, Enrica, et al.
Publicado: (2020)

Correction: Disparate In Vivo Efficacy of FTY720 in Xenograft Models of Philadelphia Positive and Negative B-lineage Acute Lymphoblastic Leukemia
por: Wallington-Beddoe, Craig T., et al.
Publicado: (2012)

Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma
por: Tea, Melinda N., et al.
Publicado: (2020)

Correction to: Variations in haematological and biochemical parameters in healthy ponies
por: Witkowska-Piłaszewicz, Olga, et al.
Publicado: (2021)

Targeting the integrated stress response in hematologic malignancies
por: Nwosu, Gus O., et al.
Publicado: (2022)

Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study
por: Oliva, A., et al.
Publicado: (2022)

Correction to: Identification and distribution of gene clusters required for synthesis of sphingolipid metabolism inhibitors in diverse species of the filamentous fungus Fusarium
por: Kim, Hye-Seon, et al.
Publicado: (2020)

Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies
por: Kitatani, Kazuyuki, et al.
Publicado: (2015)

Prognostic and predictive biomarker developments in multiple myeloma
por: Wallington-Beddoe, Craig T., et al.
Publicado: (2021)

Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
por: Huebecker, Mylene, et al.
Publicado: (2020)

Correction: Patterns of infection and impact on outcome in haematology patients admitted to intensive care
por: Jose, Ricardo, et al.
Publicado: (2012)

Targeting Metabolism and Autophagy in the Context of Haematologic Malignancies
por: Banerji, Versha, et al.
Publicado: (2012)

Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition
por: Bennett, Melissa K., et al.
Publicado: (2021)

Correction: The Sphingolipid Receptor S1PR2 Is a Receptor for Nogo-A Repressing Synaptic Plasticity
Publicado: (2014)

Authors' Correction
Publicado: (1963)

Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia
por: Bassal, Mahmoud A., et al.
Publicado: (2022)

Author Correction: On the thermodynamic origin of metabolic scaling
por: Ballesteros, Fernando J., et al.
Publicado: (2018)

Author Correction: Loss-of-function uORF mutations in human malignancies
por: Schulz, Julia, et al.
Publicado: (2021)

Correction: Author's Reply
por: Attaran, Amir
Publicado: (2006)

Correction: Author's Reply
por: Krleža-Jerić, Karmela
Publicado: (2006)

Author Correction: Metabolic changes in Medaka fish induced by cyanobacterial exposures in mesocosms: an integrative approach combining proteomic and metabolomic analyses
por: Sotton, Benoît, et al.
Publicado: (2018)

Author Correction: Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells
por: Vallejo, Jenifer, et al.
Publicado: (2022)

Author Correction: Metabolic reconfiguration enables synthetic reductive metabolism in yeast
por: Yu, Tao, et al.
Publicado: (2023)

Correction to: Serum biochemistry and haematology in wild and captive bearded seals (Erignathus barbatus) from Svalbard, Norway
por: Tryland, Morten, et al.
Publicado: (2021)

Author Correction: Disordered metabolism in mice lacking irisin
por: Luo, Yunyao, et al.
Publicado: (2021)

Author Correction: Disordered metabolism in mice lacking irisin
por: Luo, Yunyao, et al.
Publicado: (2023)

Correction: Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the Brain
por: Wang, Kai, et al.
Publicado: (2018)

Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress
por: Wallington-Beddoe, Craig T., et al.
Publicado: (2017)

Author Correction: A practical guide for mutational signature analysis in hematological malignancies
por: Maura, Francesco, et al.
Publicado: (2019)

Author Correction: Biopsy bacterial signature can predict patient tissue malignancy
por: Hogan, Glenn, et al.
Publicado: (2022)

Publisher Correction: Sphingolipid serum profiling in vitamin D deficient and dyslipidemic obese dimorphic adults
por: Al-Daghri, Nasser M., et al.
Publicado: (2020)

Author Correction: A deep learning approach to identifying immunogold particles in electron microscopy images
por: Jerez, Diego, et al.
Publicado: (2021)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

Author Correction: Biodegradation and metabolic pathway of sulfamethoxazole by Sphingobacterium mizutaii
por: Song, Jinlong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kqr64ill0u8o5kk0hpe2s9bj6u